Loading...
OTCM
XCRT
, Last price  
USD
Name

Xcelerate Inc

Chart & performance

D1W1MN
OTCM:XCRT chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
11.84%
Rev. 5Y
-22.89%
Div Yld LY
—
Div Yld TTM
—
Revenues
0
-100.00%
0001,931,5702,066,9442,197,0992,593,1764,258,2503,996,1784,116,74900001,122,0852,219,2320
Net income
-1m
L+76.91%
-4,092-2,00804,989-1,440,183-2,013,399-884,259-107,552-108,82840,8810-13,249-231,026-844,609-2,750,700-688,730-1,218,458
CFO
-379k
L-51.52%
-4,092-2,008012,397-525,016-271,32950,425-60,491-24,518-46,4610-13,249-145,668-137,940-713,087-781,522-378,860

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Xcelerate Inc. specializes in sourcing and integrating engineering expertise and patents, which it then applies to nascent medical technology ventures. The firm's offerings are subsequently deployed within regulated clinical settings for rigorous evaluation, validation, and real-world implementation. Beyond this, the company oversees a comprehensive, full-spectrum approach to medical technology creation and deployment. Established in 1996, the Mauldin, South Carolina-based entity was previously known as Union Dental Holdings, Inc. before rebranding as Xcelerate Inc.
IPO date
Oct 06, 2004
Employees
24
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT